Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-06-25FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approves a supplemental application for NovoLog (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2010-06-25FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk.
-
FDA approval · 2010-06-25FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN 70/30 (human insulin) by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2010-06-25Clinical Trial Update: Mechanism of Fatty Acid-induced Impairment of Glucose-simulated Insulin Secretion - Effect of Buphenyl [Phase 4]
Phase 4 clinical trial update examining the mechanism of fatty acid–induced impairment of glucose-stimulated insulin secretion and the effec…
-
CLINICAL_TRIALS trial_result · 2010-06-17Clinical Trial Update: I Am Able: Population Based Rehabilitation in a Family Health Team [NA]
A completed clinical trial update for a population-based rehabilitation program (I Am Able) in a family health team, assessing management of…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-06-16Clinical Trial Update: In-Clinic and Home-Use Study of a New Blood Glucose Monitoring System [NA]
This update reports the completed results of a clinical trial evaluating a new blood glucose monitoring system for in-clinic and home use. R…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Validation Study of G4 User Interface
Completed validation study of the G4 user interface by Tandem Diabetes Care in individuals with diabetes mellitus.
-
FDA approval · 2010-06-10FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN N (insulin human) filed by Eli Lilly and Company.
-
FDA approval · 2010-06-10FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin 70/30 (insulin human) by Eli Lilly and Company.
-
FDA approval · 2010-06-10FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental aplikasi for Humulin R (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2010-06-03Clinical Trial Update: Performance Study Using the OptiScanner on Healthy Diabetics [Phase 1]
A Phase 1 performance study evaluated the OptiScanner in healthy individuals with diabetes to assess safety and functionality.
-
CLINICAL_TRIALS trial_result · 2010-06-03Clinical Trial Update: Effects of Exercise Behavior Modification on Plasma Adiponectin and Insulin Resistance in High Risk Subjects of Diabetes [NA]
This completed clinical trial evaluated whether exercise behavior modification affects plasma adiponectin levels and insulin resistance in i…
-
CLINICAL_TRIALS trial_result · 2010-05-27Clinical Trial Update: Treat Arterial Hypertension and Diabetes in Rural Africa [NA]
A completed clinical trial sponsored by Cooperation Afrique evaluating treatment strategies for diabetes and hypertension in rural Africa.
-
CLINICAL_TRIALS trial_result · 2010-05-18Clinical Trial Update: Evaluation of GLUCOFACTS® Deluxe Diabetes Management System [NA]
A clinical trial evaluating the GLUCOFACTS Deluxe Diabetes Management System by Ascensia Diabetes Care has completed, and results were poste…
-
CLINICAL_TRIALS trial_result · 2010-05-12Clinical Trial Update: A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma [Phase 3]
A completed Phase 3 trial assessing the usefulness and safety of inhaled insulin in individuals with asthma and diabetes mellitus, with resu…
-
FDA approval · 2010-05-07FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
FDA Supplemental Application approval for insulin aspart protamine and insulin aspart mix 70/30 (NovoNordisk), indicating regulatory authori…
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: First in Man Study With SLV341 [Phase 1]
First-in-man Phase 1 study of SLV341 for diabetes was terminated.
-
CLINICAL_TRIALS trial_result · 2010-04-13Clinical Trial Update: A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds [Phase 2]
Phase 2 study assessing the safety and efficacy of Thymosin Beta-4 for corneal wound healing in diabetes; the trial was terminated, with res…
-
CLINICAL_TRIALS trial_result · 2010-04-13Clinical Trial Update: Characterization of Low Density Lipoprotein and Mechanism of the Pro Aggregant Effect Through Oxidant Stress and Lipid Exchange
This completed clinical trial update investigates LDL characterization and the pro-aggregant effects of oxidative stress and lipid exchange,…
-
CLINICAL_TRIALS trial_result · 2010-04-13Clinical Trial Update: The Effectiveness of Photographic Educational Material on Carbohydrate Counting for Adolescents With Diabetes [NA]
A clinical trial update assessing whether photographic educational materials improve carbohydrate counting in adolescents with diabetes.
-
CLINICAL_TRIALS trial_result · 2010-04-08Clinical Trial Update: Renal and Hormonal Effects of Pioglitazone [Phase 4]
Phase 4 study evaluating the renal and hormonal effects of pioglitazone in people with diabetes and hypertension; the trial completed and re…
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Tolerance to Hemodialysis in Insulin-Requiring Diabetic Patients: BD vs AFB With Blood Volume Biofeedback [NA]
A clinical trial comparing BD versus AFB with blood-volume biofeedback to improve tolerance to hemodialysis in insulin-requiring diabetic pa…
-
CLINICAL_TRIALS trial_result · 2010-03-30Clinical Trial Update: Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)
A completed clinical trial evaluating the efficacy of rosuvastatin (Crestor) in Korean patients with dyslipidemia and diabetes.
-
CLINICAL_TRIALS research · 2010-03-30Clinical Trial Update: Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics [Phase 4]
Phase 4 clinical trial investigating the effects of valsartan and aliskiren on hemostatic indices in hypertensive individuals with diabetes;…
-
CLINICAL_TRIALS trial_result · 2010-03-30Clinical Trial Update: Testosterone Replacement in Diabetes With Vascular Disease (Version 2) [Phase 4]
A Phase 4 clinical trial update on testosterone replacement in adults with diabetes mellitus and peripheral vascular disease; the study stat…